Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001953912 | SCV002239101 | pathogenic | Glycogen storage disease type III | 2021-04-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp194Glyfs*7) in the AGL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGL are known to be pathogenic (PMID: 19299494). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with glycogen storage disease type III (PMID: 19951495). This variant is also known as p.Thr193ThrfsX8 in the literature. For these reasons, this variant has been classified as Pathogenic. |